Tuberculosis Diagnostics Market Worth USD 3.1 Billion By 2024: Grand View Research, Inc.
The global tuberculosis diagnostics market is expected to
reach USD 3.1 billion by 2024, according to a new report by Grand View
Research, Inc. Advent of advanced diagnostic methods such as Interferon-gamma
Release Assay (IGRA), serological methods, and nucleic acid testing have
resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC)
technologies such as antigen assays are also promoting the diagnosis rate of
TB.
These advanced methods including POC diagnostics are
affordable, accurate, simple, and yield quick results. Furthermore, the rising
burden of TB is the primary factor responsible for the lucrative market growth.
As per the World Health Organization, the global estimates of patients
afflicted with TB were around 9.6 million in 2014. This high prevalence rate
has led the government, healthcare organizations, research institutes, and
market players to initiate endeavors directed toward containing the incidence
of this infectious disease.
The increasing screening rate in the high burden regions,
affordability of diagnostics, advanced methodologies, faster clinical
decisions, and reduction in mortality rate are the focal areas of development.
Improved preventive and curative diagnosis rates are the end results of these
initiatives. This has led to a subsequent upsurge in the demand for diagnostic
tests and the TB diagnostics market.
Browse full research report on Tuberculosis Diagnostics
Market: http://www.grandviewresearch.com/industry-analysis/tuberculosis-diagnostics-market
Further key findings from the study suggest:
- Based
on tests type, the tuberculosis diagnostics market is segmented into
radiographic methods, diagnostic laboratory methods, nucleic acid testing,
phage assay, detection of latent infection, cytokine detection assay, and
detection of drug resistance.
- Diagnostic
laboratory tests dominated the test type segment with 38.0% market share
in 2015 as they are cost efficient and easy-to-perform. Diagnostic
laboratory tests include smear microscopy and culture-based tests. The
high burden regions rely on these methodologies due to their financial and
technical incapability to incorporate advanced technologies thus
contributing to the growth of the diagnostic laboratory tests segment.
- However,
compromised accuracy and the longer processing time are the limiting factor
for the diagnostics. Hence, healthcare agencies are striving to implement
advanced techniques in the developing regions.
- As a
result, nucleic acid tests segment and the latent infection detection
segment, which includes skin tests and IGRA, are likely to exhibit a
profitable growth rate. These methods overcome the aforementioned
limitations thus improving affordability, processing time and accuracy of
the diagnostic method.
- Drug
resistance in tuberculosis is one of the primary concerns for healthcare professionals
as improper treatment due to wrong drug regimen and incorrect dosage forms
lead to the development of drug resistance in TB patients undergoing
treatment. Hence, the drug resistance detection segment is also
anticipated to witness lucrative growth.
- Asia
Pacific owing to its huge population base and high burden of TB dominated
the global TB diagnostics market in 2015. As per the WHO, countries such
as India, China, Afghanistan, and Indonesia are priority regions for
control of this communicable disease.
- The
players in the TB testing market include Thermo Fisher Scientific, Inc.,
Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson
and Company, F. Hoffmann-La Roche AG, bioMérieux SA, Sanofi, Cepheid, Hain
Lifescience GmbH, and QIAGEN.
- New
product launches, collaboration, mergers & acquisitions, and regional
expansion are the key strategic initiatives undertaken by these industry
players
- For
instance, in July 2016, bioMérieux launched a novel CE marked database and
reagents kit VITEK MS for the identification of TB. This new product
launch is anticipated to help the company increase its market share.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the global tuberculosis
diagnostics market on the basis of test type, and region.
Global Tuberculosis Diagnostics Test Type Outlook
(Revenue, USD Million, 2013 - 2024)
- Radiographic
Method
- Diagnostic
Laboratory Methods
- Smear
Microscopy
- Culture-based
Test
- Nucleic
Acid Testing
- Phage
Assay
- Detection
of Latent Infection
- Cytokine
Detection Assay
- Detection
of Drug Resistance
- Other
Methods
Tuberculosis Diagnostics Regional Outlook (Revenue, USD
Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Russian
Federation
- Asia
Pacific
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
Comments
Post a Comment